Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(2Z)-2-(4-Ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)acetamide is a Bilirubin (B385300) oxidation end product that results from the oxidative degradation of heme and hemoglobin. It is hypothesized to be associated with diseases such as subarachnoid hemorrhage induced cerebral vasospasm, in addition to altering potassium channel activity.